CLOVER HEALTH INVESTMENTS CO (CLOV) Forecast, Price Target & Analyst Ratings

NASDAQ:CLOV • US18914F1030

Current stock price

1.75 USD
-0.05 (-2.78%)
At close:
1.7408 USD
-0.01 (-0.53%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CLOVER HEALTH INVESTMENTS CO (CLOV).

Forecast Snapshot

Consensus Price Target

Price Target
$2.60
+ 48.63% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.03
Revenue Estimate
729.19M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
76.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$2.60
Upside
+ 48.63%
From current price of $1.75 to mean target of $2.60, Based on 10 analyst forecasts
Low
$1.77
Median
$2.68
High
$3.36

Price Target Revisions

1 Month
-10.92%
3 Months
-21.13%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for CLOV. The average price target is 2.6 USD. This implies a price increase of 48.63% is expected in the next year compared to the current price of 1.75.
The average price target has been revised downward by 21.13% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CLOV Current Analyst RatingCLOV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

CLOV Historical Analyst RatingsCLOV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
76.00%
CLOV was analyzed by 10 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about CLOV.
In the previous month the buy percentage consensus was at a similar level.
CLOV was analyzed by 10 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-20Canaccord GenuityMaintains Buy -> Buy
2026-03-05Leerink PartnersMaintains Market Perform -> Market Perform
2026-01-20Canaccord GenuityMaintains Buy -> Buy
2025-11-06Canaccord GenuityMaintains Buy -> Buy
2025-08-07Canaccord GenuityMaintains Buy -> Buy
2025-08-06UBSMaintains Neutral -> Neutral
2025-03-03Canaccord GenuityMaintains Buy -> Buy
2024-12-17Craig-HallumInitiate Buy
2024-10-07UBSInitiate Neutral
2023-08-11CitigroupMaintains Neutral -> Neutral
2023-03-06Canaccord GenuityMaintains Buy
2023-03-06Credit SuisseMaintains Underperform
2022-11-16CitigroupMaintains Neutral
2022-11-08SVB LeerinkMaintains Market Perform
2022-08-09Credit SuisseMaintains Underperform
2022-08-09CitigroupMaintains Neutral
2022-05-10SVB LeerinkMaintains Market Perform
2022-02-25SVB LeerinkMaintains Market Perform
2022-02-02Cowen & Co.Upgrade Underperform -> Market Perform
2022-02-02Canaccord GenuityInitiate Buy
2022-01-19SVB LeerinkInitiate Market Perform
2022-01-07Credit SuisseDowngrade Neutral -> Underperform
2021-11-15Credit SuisseMaintains Neutral
2021-09-10Cowen & Co.Initiate Underperform
2021-07-12JP MorganDowngrade Neutral -> Underweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.03
Revenue Estimate
729.19M
Revenue Q2Q
57.72%
EPS Q2Q
N/A
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
5.46%
Revenue (3 Months)
9.90%
EPS (1 Month)
349.78%
EPS (3 Months)
349.78%

Next Earnings Summary

CLOV is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is 0.03 USD and the consensus revenue estimate is 729.19M USD.
The next earnings revenue estimate has been revised upward by 9.9% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2031

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
CLOV revenue by date.CLOV revenue by date.
1.261B
-63.74%		1.371B
8.77%		1.924B
40.34%		2.929B
52.21%		3.389B
15.71%		3.775B
11.39%		3.766B
-0.24%		4.445B
18.03%		5.757B
29.52%
EBITDA
YoY % growth
CLOV ebitda by date.CLOV ebitda by date.
-177.054M
52.11%		-44.13M
75.08%		-83.843M
-89.99%		49.279M
158.78%		68.572M
39.15%		110.83M
61.63%		N/AN/AN/A
EBIT
YoY % growth
CLOV ebit by date.CLOV ebit by date.
-179.563M
51.59%		-45.461M
74.68%		-85.529M
-88.14%		15.448M
118.06%		36.154M
134.04%		64.836M
79.33%		199.89M
208.30%		288.95M
44.55%		359.8M
24.52%
Operating Margin
CLOV operating margin by date.CLOV operating margin by date.
-14.24%-3.32%-4.44%0.53%1.07%1.72%5.31%6.50%6.25%
EPS
YoY % growth
CLOV eps by date.CLOV eps by date.
-0.44
40.94%		-0.09
79.55%		-0.17
-88.89%		-0.02
86.00%		0.01
157.14%		0.08
462.64%		0.31
300.00%		N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		0.030.03
253.00%		-0.01
86.39%		-0.06
35.40%		0.08
150.00%		0.05
50.00%		-0.02
-199.85%		-0.09
-42.11%		0.12
60.00%		0.08
77.78%		0.00
100.00%		-0.11
-22.22%
Revenue
Q2Q % growth		729.19M
57.72%		740.12M
54.96%		743.06M
49.61%		723.03M
48.25%		845.06M
15.89%		858.21M
15.96%		859.23M
15.63%		826.96M
14.37%		916.09M
8.41%		923.37M
7.59%		910.58M
5.98%		867.96M
4.96%
EBITDA
Q2Q % growth		35.987M
4,553.84%		29.953M
408.83%		9.429M
140.80%		-19.325M
59.43%		57.038M
58.50%		40.622M
35.62%		4.758M
-49.54%		-34.757M
-79.85%		77.357M
35.62%		57.742M
42.14%		14.341M
201.41%		-47.848M
-37.67%
EBIT
Q2Q % growth		25.492M
2,100.94%		21.29M
301.63%		694.62K
102.85%		-27.961M
43.31%		49.276M
93.30%		32.655M
53.38%		-3.259M
-569.16%		-42.519M
-52.07%		76.928M
56.12%		57.314M
75.51%		13.913M
526.92%		-48.277M
-13.54%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CLOV Yearly Revenue VS EstimatesCLOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
CLOV Yearly EPS VS EstimatesCLOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -0.5 -1

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
34.81%
EPS Next 5 Year
39.62%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
24.80%
Revenue Next 5 Year
18.01%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
47.64%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CLOVER HEALTH INVESTMENTS CO / CLOV Forecast FAQ

What is the average price target for CLOVER HEALTH INVESTMENTS CO (CLOV) stock?

10 analysts have analysed CLOV and the average price target is 2.6 USD. This implies a price increase of 48.63% is expected in the next year compared to the current price of 1.75.

What is the next earnings date for CLOV stock?

CLOVER HEALTH INVESTMENTS CO (CLOV) will report earnings on 2026-05-04.

What are the consensus estimates for CLOV stock next earnings?

The consensus EPS estimate for the next earnings of CLOVER HEALTH INVESTMENTS CO (CLOV) is 0.03 USD and the consensus revenue estimate is 729.19M USD.

What is the expected long term growth rate for CLOVER HEALTH INVESTMENTS CO (CLOV)?

The expected long term growth rate for CLOVER HEALTH INVESTMENTS CO (CLOV) is 24.8%.